UPM Pharmaceuticals is an independent CDMO specializing in formulation development, cGMP manufacturing, analytical methods development, stability testing and commercial manufacturing for oral solid dosage forms and semi-solid creams and ointments. With 500,000 square feet of manufacturing space, UPM’s 250 employees provide customized product development services and scientific solutions to pharmaceutical and biotechnology companies of all sizes, from virtual to multi-billion-dollar big pharma. As a private, family-owned CDMO, UPM has the flexibility to quickly advance clients’ projects from concept to commercialization, which is further facilitated by the organization’s ability to make rapid decisions without having to go through a corporate bureaucracy.